Amoxicillin And Clavulanate Potassium Powder, For Suspension
Product Images NDC 73043-010

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Amoxicillin And Clavulanate Potassium (NDC 73043-010). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Devatis, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Label (250 mg 150 mL Label)

Label for amoxicillin and clavulanate potassium oral suspension USP, 250 mg/62.5 mg per 5 mL, powder for suspension, 150 mL when reconstituted. The label includes mixing directions, dosage information, and storage instructions. Manufactured by Deva Holding A.S. and distributed by Devatis, Inc.*

FDA Label Image

Amoxicillin Structure (Amoxicillin Structure)

Chemical structure of amoxicillin and clavulanate potassium showing the molecular arrangement with key functional groups and bonds, including a beta-lactam ring, hydroxyl group, and other characteristic components.*

FDA Label Image

Clavulanate Potassium Structure (Clavulanate Structure)

Chemical structure of amoxicillin and clavulanate potassium, depicted as a molecular diagram showing the core beta-lactam ring, attached hydroxyl, carboxyl, and potassium salt groups.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.